{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T08:56:13Z","timestamp":1766048173654},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.lpm.2009.09.016","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T19:41:10Z","timestamp":1258659670000},"page":"530-538","source":"Crossref","is-referenced-by-count":21,"title":["Prise en charge de la toxoplasmose cong\u00e9nitale en France\u00a0: donn\u00e9es actuelles"],"prefix":"10.1016","volume":"39","author":[{"given":"Patricia","family":"Garcia-M\u00e9ric","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Franck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Dumon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Piarroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2009.09.016_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0020-7519(98)00023-X","article-title":"Advance in the life cycle of Toxoplasma gondii","volume":"28","author":"Dubey","year":"1998","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.lpm.2009.09.016_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1773-035X(08)71783-0","article-title":"Toxoplasmose et grossesse","volume":"402","author":"Bessi\u00e8res","year":"2008","journal-title":"Revue Francophone des Laboratoires"},{"key":"10.1016\/j.lpm.2009.09.016_bib3","first-page":"117","article-title":"Toxoplasmose chez les femmes enceintes en France\u00a0: \u00e9volution de la s\u00e9ropr\u00e9valence et de l\u2019incidence et facteurs associ\u00e9s, 1995-2003","volume":"14-15","author":"Berger","year":"2008","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.lpm.2009.09.016_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/INF.0b013e3181966020","article-title":"Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection","volume":"28","author":"Robert-Gangneux","year":"2009","journal-title":"Ped Infect Dis J"},{"key":"10.1016\/j.lpm.2009.09.016_bib5","first-page":"489","article-title":"Preconception seroconversion and maternal seronegativity at delivery do not rule out the risk of congenital toxoplasmosis","volume":"9","author":"Chemla","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.lpm.2009.09.016_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/pd.1970140514","article-title":"Prenatal diagnosis of severe fetal toxoplasmosis as a result of toxoplasmic reactivation in an HIV-1 seropositive woman","volume":"14","author":"Marty","year":"1994","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.lpm.2009.09.016_bib7","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/pd.1970151216","article-title":"Recurrent congenital toxoplasmosis in a woman with lupus erythematosus","volume":"15","author":"D\u2019Ercole","year":"1995","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.lpm.2009.09.016_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.inf.0000115949.12206.69","article-title":"Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman","volume":"23","author":"Kodjikian","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lpm.2009.09.016_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0002-9394(03)00191-0","article-title":"Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier","volume":"136","author":"Silveira","year":"2003","journal-title":"Am J Ophtalmol"},{"key":"10.1016\/j.lpm.2009.09.016_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/595793","article-title":"Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection and review","volume":"199","author":"Elbez-Rubinstein","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2009.09.016_bib11","unstructured":"Leroy V, Raeber PA, Petersen E, Salmi LR, Kaminski M, Villena I et al. National public health policies and routine programs to prevent congenital toxoplasmosis. European TOXO prevention project 2005. http:\/\/eurotoxo.isped.u-bordeaux2.fr\/WWW_PUBLIC\/DOC\/EUROTOXO_R1_P3_European_national_policies_Dec2005.pdf."},{"key":"10.1016\/j.lpm.2009.09.016_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.siny.2007.01.011","article-title":"Toxoplasmosis","volume":"12","author":"Petersen","year":"2007","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.lpm.2009.09.016_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2007.77.405","article-title":"Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade","volume":"77","author":"Jones","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2009.09.016_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00417-005-1164-3","article-title":"Ocular manifestations in congenital toxoplasmosis","volume":"244","author":"Kodjikian","year":"2006","journal-title":"Graefe's Arch Clin Exp Ophtalmol"},{"key":"10.1016\/j.lpm.2009.09.016_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2007.07.013","article-title":"Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis","volume":"144","author":"Tan","year":"2007","journal-title":"Am J Ophtalmol"},{"key":"10.1016\/j.lpm.2009.09.016_bib16","doi-asserted-by":"crossref","unstructured":"The SYROCOT (Systematic review on congenital toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis\u00a0: a meta- analysis of individual patient's data. Lancet 2007; 369:115-22.","DOI":"10.1016\/S0140-6736(07)60072-5"},{"key":"10.1016\/j.lpm.2009.09.016_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ophtha.2007.06.022","article-title":"Longitudinal study of new eye lesions in treated congenital toxoplasmosis","volume":"115","author":"Phan","year":"2008","journal-title":"Ophtalmology"},{"key":"10.1016\/j.lpm.2009.09.016_bib18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1542\/peds.2007-2169","article-title":"Predictors of retinochoroiditis in children with congenital toxoplamosis\u00a0: European prospective cohort study","volume":"121","author":"Freeman","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2009.09.016_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajo.2008.04.033","article-title":"Longitudinal study of new eye lesions in children who were not treated during the first year of life","volume":"146","author":"Phan","year":"2008","journal-title":"Am J Ophtalmol"},{"key":"10.1016\/j.lpm.2009.09.016_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1526-9523(03)00279-4","article-title":"Maternal serologic screening for toxoplasmosis","volume":"48","author":"Pinard","year":"2003","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.lpm.2009.09.016_bib21","series-title":"Infections virales et toxoplasmose materno-foetales","author":"Thulliez","year":"2001"},{"key":"10.1016\/j.lpm.2009.09.016_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(94)91054-5","article-title":"Termination of pregnancy for maternal toxoplasmosis","volume":"344","author":"Berrebi","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2009.09.016_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1471-0528.2005.00486.x","article-title":"Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid","volume":"112","author":"Thalib","year":"2005","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2009.09.016_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.patbio.2006.11.001","article-title":"Apport de la PCR quantitative dans le diagnostic de la toxoplasmose\u00a0: la voie de la standardisation?","volume":"55","author":"Maubon","year":"2007","journal-title":"Pathologie Biologie"},{"key":"10.1016\/j.lpm.2009.09.016_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ajog.2003.09.039","article-title":"Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii","volume":"190","author":"Romand","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2009.09.016_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diagmicrobio.2008.09.009","article-title":"Quantitative real-time polymerase chain reaction for the accurate detection of Toxoplasma gondii in amniotic fluid","volume":"63","author":"Kasper","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.lpm.2009.09.016_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/S0074-02762009000200038","article-title":"Diagnosis of congenital toxoplasmosis\u00a0: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis","volume":"104","author":"Bessi\u00e8res","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.lpm.2009.09.016_bib28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.reprotox.2005.10.006","article-title":"Congenital toxoplasmosis \u2013 prenatal aspects of Toxoplasma gondii infection","volume":"21","author":"Rorman","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.lpm.2009.09.016_bib29","first-page":"35","article-title":"Signes \u00e9chographiques de la toxoplasmose cong\u00e9nitale","volume":"10","author":"Jacquemard","year":"2003","journal-title":"Arch P\u00e9diatr"},{"key":"10.1016\/j.lpm.2009.09.016_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/INF.0b013e318134286d","article-title":"Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis","volume":"27","author":"Kieffer","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lpm.2009.09.016_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2006.11.002","article-title":"Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound\u00a0: A study of 36 cases","volume":"135","author":"Berrebi","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.lpm.2009.09.016_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1542\/peds.2005-1530","article-title":"Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis\u00a0: implications for compensatory intervention strategies","volume":"118","author":"Roizen","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2009.09.016_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00417-005-1164-3","article-title":"Ocular manifestations in congenital toxoplasmosis","volume":"244","author":"Kodjikian","year":"2006","journal-title":"Graefes Arch Clin Exp Ophtalmol"},{"key":"10.1016\/j.lpm.2009.09.016_bib34","article-title":"Ocular manifestations of congenital toxoplasmosis","author":"Melamed","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.lpm.2009.09.016_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(00)00300-6","article-title":"Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests","volume":"94","author":"Bessi\u00e8res","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.lpm.2009.09.016_bib36","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JCM.39.6.2267-2271.2001","article-title":"Strategy for diagnosis of congenital toxoplasmosis\u00a0: evaluation of methods comparing mothers and newborns and standard methods for post-natal detection of immunoglobulin G, M and A antibodies","volume":"39","author":"Pinon","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.lpm.2009.09.016_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/00365549850160963","article-title":"Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis\u00a0: follow-up of 78 cases between 1980 and 1997","volume":"30","author":"Villena","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.lpm.2009.09.016_bib38","unstructured":"Afssa. Rapport du groupe de travail \u00ab\u00a0Toxoplasm gondii\u00a0\u00bb. Toxoplasmose\u00a0: Etat des connaissances et \u00e9valuation du risque li\u00e9 \u00e0 l\u2019alimentation. 2005. http:\/\/fulltext.bdsp.ehesp.fr."},{"key":"10.1016\/j.lpm.2009.09.016_bib39","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0755-4982(05)84259-9","article-title":"Effets secondaires du traitement ant\u00e9natal de la toxoplasmose cong\u00e9nitale","volume":"34","author":"Chemla","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2009.09.016_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajog.2004.07.031","article-title":"Toxoplasmosis Study Group. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening","volume":"192","author":"Boyer","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2009.09.016_bib41","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0002-9378(99)70224-3","article-title":"Treatment of toxoplasmosis during pregnancy\u00a0: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year","volume":"180","author":"Foulon","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2009.09.016_bib42","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/ije\/30.6.1303","article-title":"Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii\u00a0: retrospective cohort study of 554 mother-child pairs in Lyon, France","volume":"30","author":"Gilbert","year":"2001","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.lpm.2009.09.016_bib43","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1080\/08035250500251999","article-title":"European Multicenter Study on Congenital Toxoplasmosis. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy\u00a0: a cohort study in 13 European centres","volume":"94","author":"Gras","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.lpm.2009.09.016_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/14787210.1.1.175","article-title":"Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis\u00a0: what are the options?","volume":"1","author":"Petersen","year":"2003","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.lpm.2009.09.016_bib45","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/501362","article-title":"Time to screen for congenital toxoplasmosis ?","volume":"42","author":"Kami","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2009.09.016_bib46","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/ije\/30.6.1309","article-title":"Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis","volume":"30","author":"Gras","year":"2001","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.lpm.2009.09.016_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0929-693X(01)00687-X","article-title":"Traitement de la toxoplasmose cong\u00e9nitale non s\u00e9v\u00e8re par sulfadiazine et pyrim\u00e9thamine en continu pendant un an\u00a0: \u00e0 propos de 46 cas","volume":"9","author":"Kieffer","year":"2002","journal-title":"Arch P\u00e9diatr"},{"key":"10.1016\/j.lpm.2009.09.016_bib48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jpba.2004.09.001","article-title":"Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis","volume":"36","author":"Johannessen","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.lpm.2009.09.016_bib49","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1128\/AAC.48.10.3794-3800.2004","article-title":"Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis","volume":"48","author":"Corvaisier","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lpm.2009.09.016_bib50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2004.02077.x","article-title":"Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis","volume":"57","author":"Trenque","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2009.09.016_bib51","first-page":"1001","article-title":"Congenital toxoplasmosis. Transitory negative serology","volume":"30","author":"Jaisson-Hot","year":"2001","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2009.09.016_bib52","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0929-693X(97)86088-5","article-title":"Etude des pouss\u00e9es cliniques \u00e9volutives et des rebonds s\u00e9rologiques d\u2019enfants atteints de toxoplasmose cong\u00e9nitale et suivis durant les 2 premi\u00e8res ann\u00e9es de vie","volume":"4","author":"Fortier","year":"1997","journal-title":"Arch P\u00e9diatr"},{"key":"10.1016\/j.lpm.2009.09.016_bib53","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004310100805","article-title":"Serological rebound in congenital toxoplasmosis\u00a0: long-term follow-up of 133 children","volume":"160","author":"Wallon","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.lpm.2009.09.016_bib54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.66.5.767","article-title":"Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection","volume":"66","author":"Wilson","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2009.09.016_bib55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0140-6736(86)90785-3","article-title":"Results of 20-year follow-up of congenital toxoplasmosis","volume":"1","author":"Koppe","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2009.09.016_bib56","first-page":"855","article-title":"Ocular prognosis in congenital toxoplasmosis\u00a0: the role of treatment. Preliminary communication","volume":"31","author":"Couvreur","year":"1984","journal-title":"Ann Pediatr"},{"key":"10.1016\/j.lpm.2009.09.016_bib57","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1542\/peds.113.6.1567","article-title":"Long-term ocular prognosis in 327 children with congenital toxoplasmosis","volume":"113","author":"Wallon","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2009.09.016_bib58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/adc.2004.066514","article-title":"The national neonatal screening programme for congenital toxoplasmosis in Denmark\u00a0: results from the initial four years, 1999-2002","volume":"91","author":"Schmidt","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.lpm.2009.09.016_bib59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","article-title":"An update on current practices in the management of ocular toxoplasmosis","volume":"134","author":"Holland","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.lpm.2009.09.016_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","article-title":"The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis","volume":"134","author":"Silveira","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.lpm.2009.09.016_bib61","first-page":"1368","article-title":"Anti-toxoplasmosis drugs","volume":"2","author":"Derouin","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.lpm.2009.09.016_bib62","first-page":"122","article-title":"La toxoplasmose cong\u00e9nitale\u00a0: mise en place d\u2019un dispositif de surveillance en France","volume":"14-15","author":"King","year":"2008","journal-title":"BEH th\u00e9matique"},{"key":"10.1016\/j.lpm.2009.09.016_bib63","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/501360","article-title":"toxoplasmosis study group. outcome of treatment for congenital toxoplasmosis, 1981-2004\u00a0: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study","volume":"42","author":"McLeod","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2009.09.016_bib64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S0074-02762009000200025","article-title":"Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis","volume":"104","author":"Ch\u00eane","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209004783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209004783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T16:22:21Z","timestamp":1685204541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498209004783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0755498209004783"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2009.09.016","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}